These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9371324)

  • 1. Role of hematopoietic growth factors in transfusion medicine.
    Goodnough LT
    Curr Opin Hematol; 1994 Nov; 1(6):462-70. PubMed ID: 9371324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic growth factors in myelodysplastic syndromes.
    Blinder VS; Roboz GJ
    Curr Hematol Rep; 2003 Nov; 2(6):453-8. PubMed ID: 14561388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic growth factors in cancer chemotherapy.
    Lieschke GJ; Foote M; Morstyn G
    Cancer Chemother Biol Response Modif; 1997; 17():363-89. PubMed ID: 9551221
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hematopoietic growth factors in oncology and hematology. Recommendations for more cost-efficient use].
    Paul C; Hast R
    Lakartidningen; 2000 Jun; 97(23):2862-6. PubMed ID: 10885223
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant growth factors.
    Goodnough LT; Anderson KC
    Transfus Sci; 1995 Mar; 16(1):45-62. PubMed ID: 10155704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic growth factors in autologous bone marrow transplantation.
    Miller AM
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):88-95. PubMed ID: 7692607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hematopoietic growth factors in transfusion medicine.
    Whitsett CF
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):23-68. PubMed ID: 7737944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth factors in allogeneic transplantation.
    Nemunaitis J
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):96-101. PubMed ID: 8211221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion support of hematology and oncology patients. The role of recombinant hematopoietic growth factors.
    Cottler-Fox M; Klein HG
    Arch Pathol Lab Med; 1994 Apr; 118(4):417-20. PubMed ID: 7909429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Akasheh M; Eastwood D; Vesole DH
    Bone Marrow Transplant; 2003 Jan; 31(2):113-6. PubMed ID: 12621492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current status of clinical indications for hematopoietic growth factors after chemo-/radiotherapy in gynecology].
    Karthaus M; Ganser A
    Zentralbl Gynakol; 1997; 119(12):585-96. PubMed ID: 9483809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
    Grossi F; Tiseo M
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):221-30. PubMed ID: 16697211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic use of myelopoietic growth factors in children after myelosuppressive and myeloablative therapy.
    Satwani P; Bessmertny O; Morris E; Cairo MS
    Curr Hematol Rep; 2003 Nov; 2(6):480-90. PubMed ID: 14561392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future directions with hematopoietic growth factors.
    Vadhan-Raj S
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S96-101. PubMed ID: 19795582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic marrow transplantation and the use of hematopoietic growth factors.
    Appelbaum FR
    Stem Cells; 1995 Jul; 13(4):344-50. PubMed ID: 7549892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic growth factors in cancer chemotherapy.
    Crawford J; Foote M; Morstyn G
    Cancer Chemother Biol Response Modif; 1999; 18():250-67. PubMed ID: 10800487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging therapeutic and supportive care approaches for the myelodisplastic syndromes.
    Mufti GJ
    Rev Clin Exp Hematol; 2004 Dec; 8(2):E4. PubMed ID: 16027102
    [No Abstract]   [Full Text] [Related]  

  • 19. The administration of growth factors post-PBPC transplantation abrogates the dose-effect of CFU-GM on the rate of PMN recovery.
    Pierelli L; Menichella G; Foddai ML; Scambia G; Salerno G; Benedetti Panici P
    Bone Marrow Transplant; 1996 Jun; 17(6):1189-90. PubMed ID: 8807136
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic potential of the hematopoietic growth factors.
    Usha D; Thatte UM; Dahanukar SA
    J Postgrad Med; 1994; 40(4):210-5. PubMed ID: 9136242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.